QPPV.COM KNOWLEDGE ASSESSMENT

EU Pharmacovigilance Compliance Monitoring: Detecting Failures Before Inspection

Test your understanding of the concepts covered by EU Pharmacovigilance Compliance Monitoring: Detecting Failures Before Inspection.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which situation most clearly illustrates false reassurance from an aggregate metric?

Overall timeliness is high, but serious cases in one affiliate show a persistent decline A metric is stratified by risk-relevant subgroup and reviewed with source data A monitoring result is linked to an investigation and subsequent effectiveness check A workload increase occurs while timeliness and quality remain stable

Question 2 of 10 Which statement best describes the QPPV's role in relation to compliance monitoring?

The QPPV must personally review every operational metric The QPPV should have appropriate visibility of material performance issues through defined governance and escalation arrangements The QPPV is responsible only for metrics related to individual case safety reports The QPPV should receive results only after all investigations and CAPAs are closed

Question 3 of 10 Which approach best supports monitoring data governance over time?

Allowing metric definitions to change without recording the changes Using clear ownership, version-controlled methodology and change control for important metrics Comparing every result with historical data regardless of definition changes Treating source-system changes as unrelated to metric interpretation

Question 4 of 10 Which use of monitoring provides the strongest evidence of CAPA effectiveness?

Showing that the CAPA record was closed on its planned completion date Showing that a relevant metric improved and remained stable over an appropriate observation period capable of detecting recurrence Showing that the team attended additional training immediately after CAPA initiation Showing that the next single reporting period had no exceptions

Question 5 of 10 Which statement best captures the relationship between monitoring and inspection readiness?

Monitoring should be designed primarily to generate reassuring inspection evidence Inspection readiness is a consequence of effective internal control, not a substitute for meaningful monitoring Inspection readiness requires more metrics regardless of whether they address important risks A monitoring programme is effective if inspectors cannot identify any dashboard exceptions

Question 6 of 10 A metric remains below its formal threshold for four consecutive quarters but worsens each quarter. What is the best response?

Take no action because the threshold has not been breached Replace the metric with one that produces a more favourable result Use trend analysis to assess persistence and significance and determine whether investigation is warranted Classify the result automatically as a critical deviation

Question 7 of 10 After a major safety-database implementation, historical timeliness appears to improve sharply. What should the organisation verify before concluding that performance improved?

That the new dashboard uses brighter visual indicators That timestamps, workflow stages, inclusion criteria and measured events are equivalent before and after the transition That the implementation project was completed on schedule That no users reported dissatisfaction with the new system

Question 8 of 10 Which statement correctly reflects the regulatory status of a monitoring threshold selected by an MAH?

Any threshold used by an MAH automatically becomes an EU-wide legal requirement An internally selected threshold may become part of the organisation's quality system but should not automatically be presented as an EU-wide legal requirement Internal thresholds have no quality-system significance unless explicitly stated in GVP A threshold is valid only if it is identical to the threshold used by the competent authority

Question 9 of 10 A threshold is exceeded, but the monitoring procedure does not specify who reviews the result or what action follows. What weakness does this demonstrate?

The metric is necessarily invalid because all thresholds must be statistical The threshold functions as a reporting mechanism rather than a complete quality-system control The result should be ignored until an inspector requests it The issue must automatically be escalated to every member of senior management

Question 10 of 10 Which interpretation is most appropriate when one serious regulatory reporting delay occurs despite excellent overall timeliness?

The delay is immaterial because the aggregate percentage is high The overall metric proves that no investigation is necessary The individual high-risk exception should be assessed separately using risk-based criteria The denominator should be changed to exclude the delayed report

EU Pharmacovigilance Compliance Monitoring: Detecting Failures Before Inspection

Cookie Settings